Bacteriophages, or simply phages, are viruses that infect and replicate within bacteria, and they hold considerable potential for combatting antibiotic-resistance and other threats to human health. Timed with the hundredth anniversary of their discovery, a new review published in the British Journal of Pharmacology examines the challenges and opportunities of developing phages as health-promoting, commercially-viable biopharmaceuticals.
2017 has undoubtedly been a standout year in the realms of telemedicine and digital health.
In telehealth alone, much has happened over the past 12 months.
My glowing genes, Rudolph!
If we didn’t already know that Rudolph the Red-Nosed Reindeer was special, that shiny proboscis of his could have resulted from the one-in-a-million transfer of genetic material from a brilliant colored coral found in the Red Sea.
Swiss drugmaker Roche has won fresh approvals for two cancer drugs in Europe and the United States, shoring up its position in new medicines as it braces for falling sales of older products.
Vicki Sato, a longtime Boston biotech entrepreneur, laid out a challenge for New York life sciences in 2018. “Stop being an initiative,” she said. “Start being a player.”
Expenditures for R&D from state government agencies increased by 17.3 percent from FY 2011 to FY 2016, reaching $2.3 billion, according to data from the Survey of State Government Research and Development, a survey sponsored by the National Science Foundation’s National Center for Science and Engineering Statistics (NCSES). Nearly two-thirds of this total – 64 percent – came from just five state governments (California, New York, Texas, Florida, and Ohio).
Today, the Greater Washington Partnership (the Partnership), a civic alliance of CEOs that together employ more than 175,000 workers in the region, released a new report that outlines why developing, attracting and retaining digital technology workers will be imperative for the Capital Region’s future growth and economic competitiveness.
The Emmes Corporation today announced its participation in a three-year study testing the results of two different opioid treatment medications. The research, published in one of the world’s oldest and best known medical journals, concluded that for those able to begin treatment, both drugs are nearly equal in their safety and effectiveness. The National Institute on Drug Abuse (NIDA) funded the research.
During the fall semester, students at Johns Hopkins who were interested in starting a company had some new options to turn to as they looked to develop their ideas and meet other entrepreneurs at the university.
Maryland is open for business and here’s another way our state supports companies seeking capital. Maryland Commerce has launched a new, searchable site that lets you search and find just the right program to fund your business. With the ability to filter by type of program, category or keyword, the Financial Incentives database is a great place to find grants, tax credits, loans and training. Give it a try!
